Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DoximityDOCS +3.00%82 Forward Rate of Return (Yacktman) % is 24.50% as of Mar. 2026, which is 10% above its 10-year median of 22.24. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.29 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 342 Healthcare Providers & Services companies, Doximity ranks better than 88.3% on this metric.
Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Doximity's forward rate of return for was 24.50%.
The historical rank and industry rank for Doximity's Forward Rate of Return (Yacktman) % or its related term are showing as below:
DOCS'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 20 Med: 22.24 Max: 25.52
Current: 24.81
During the past 8 years, Doximity's highest Forward Rate of Return was 25.52. The lowest was 20.00. And the median was 22.24.
DOCS's Forward Rate of Return (Yacktman) % is ranked better than 88.3% of 342
companies
in the Healthcare Providers & Services industry
Industry Median: 12.245
vs DOCS: 24.81
Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Doximity (NYSE:DOCS) Forward Rate of Return (Yacktman) % Explanation
Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.
Be Aware
In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.
Doximity Forward Rate of Return (Yacktman) % Related Terms
Doximity Forward Rate of Return (Yacktman) % Historical Data
* Premium members only.
The historical data trend for Doximity's Forward Rate of Return (Yacktman) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Doximity Forward Rate of Return (Yacktman) % Chart
DOCS vs WAY, PRVA, HTFL: Forward Rate of Return (Yacktman) % Comparison
For the Health Information Services subindustry, Doximity's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Doximity Forward Rate of Return (Yacktman) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Forward Rate of Return (Yacktman) % distribution charts can be found below:
* The bar in red indicates where Doximity's Forward Rate of Return (Yacktman) % falls into.
Doximity Forward Rate of Return (Yacktman) % Calculation
Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Rate of Return (Yacktman) % of 24.50% mean?
Doximity (DOCS) has a Forward Rate of Return (Yacktman) % of 24.50% as of Mar. 2026. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Doximity and its competitors. This is 10% above median its historical median of 22.24. Over the past decade, Doximity's Forward Rate of Return (Yacktman) % has ranged from 20.00 to 25.52. According to the industry distribution chart, Doximity ranks #40 out of 342 companies in the Healthcare Providers & Services industry, placing it in the top 11.7%.
Is Doximity's Forward Rate of Return (Yacktman) % too high?
Doximity's current Forward Rate of Return (Yacktman) % of 24.50% is 10% above median its 10-year median of 22.24. Over the past 10 years, this metric has ranged from a low of 20.00 to a high of 25.52. The Healthcare Providers & Services industry median Forward Rate of Return (Yacktman) % is 12.25. Doximity's value of 24.50% is 100.1% above this industry median. Based on the distribution chart, Doximity ranks #40 out of 342 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Forward Rate of Return (Yacktman) % compare to WAY and PRVA?
According to the Healthcare Providers & Services industry distribution chart, Doximity ranks #40 out of 342 companies for Forward Rate of Return (Yacktman) %. This places Doximity in the top 12% of its industry — outperforming the majority of peers. The industry median Forward Rate of Return (Yacktman) % is 12.25. Doximity's value of 24.50% is 100.1% above this benchmark. Historically, Doximity's own Forward Rate of Return (Yacktman) % has ranged from 20.00 to 25.52 over the past decade. While the company's 10-year median is 22.24 vs. the industry median of 12.25, Doximity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Rate of Return (Yacktman) % for a Healthcare Providers & Services company?
The median Forward Rate of Return (Yacktman) % among Healthcare Providers & Services companies is 12.25, based on 342 companies in the industry. Companies in the top quartile (top 25%) have a Forward Rate of Return (Yacktman) % significantly above this median, while those in the bottom quartile fall well below. However, Forward Rate of Return (Yacktman) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Doximity's current Forward Rate of Return (Yacktman) % of 24.50% is 100.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Rate of Return (Yacktman) % mean?
A high Forward Rate of Return (Yacktman) % can signal that a stock is expensive relative to its fundamentals. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Doximity and its competitors. For the Healthcare Providers & Services industry, the median Forward Rate of Return (Yacktman) % is 12.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Doximity's current Forward Rate of Return (Yacktman) % is 24.50%, which is 10% above median its own 10-year median of 22.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.29, compared to a current price of $22.46 — trading 54.4% below its estimated fair value. The current Forward Rate of Return (Yacktman) % is 24.50%, which is 10% above median its 10-year median of 22.24 and 100.1% above the Healthcare Providers & Services industry median of 12.25. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Rate of Return (Yacktman) % calculated?
Forward Rate of Return (Yacktman) % is calculated from a company's financial statements. For Doximity (DOCS), the current Forward Rate of Return (Yacktman) % is 24.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Doximity (DOCS) Overvalued in 2026?
Based on GuruFocus' analysis, Doximity stock appears to be undervalued.
The current stock price of $22.46 is trading 54.4% below its estimated GF Value™ of $49.29.
GuruFocus considers Doximity to be Significantly Undervalued.
Key valuation signals for DOCS:
Forward Rate of Return (Yacktman) %: 24.50% (10% above median its 10-year median of 22.24)
GF Value™: $49.29 vs. price of $22.46 (54.4% below fair value)
Industry Position: 100.1% above the Healthcare Providers & Services median (#40 of 342)
No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score
Get the complete analysis for DOCS
Forward Rate of Return (Yacktman) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCS has been successfully added to your 
